In utero therapy for congenital disorders using amniotic fluid stem cells. by Durrgah Latchumi Ramachandra, Sheng-Wen Steven eShaw, Sheng-Wen Steven eShaw, Panicos eShangaris, Stavros eLoukogeorgakis, Pascale V Guillot, Pascale V Guillot, Paolo eDe Coppi, Anna L David

Get full text

Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta. by Michelangelo Corcelli, Rachel Sagar, Ellen Petzendorfer, Mohammad Mehedi Hasan, Fleur S van Dijk, Anna L David, Pascale V Guillot

Get full text

TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production by Kwan-Leong Hau, Anna Maria Ranzoni, Filipa Vlahova, Kate Hawkins, Paolo De Coppi, Anna L. David, Pascale V. Guillot

Get full text

Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A by Filipa Vlahova, Kate E. Hawkins, Anna Maria Ranzoni, Kwan-Leong Hau, Rachel Sagar, Paolo De Coppi, Anna L. David, James Adjaye, Pascale V. Guillot

Get full text

The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time by Md Shaifur Rahman, Lucas-Sebastian Spitzhorn, Wasco Wruck, Carsten Hagenbeck, Percy Balan, Nina Graffmann, Martina Bohndorf, Audrey Ncube, Pascale V. Guillot, Tanja Fehm, James Adjaye

Get full text

Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. by Gemma N Jones, Dafni Moschidou, Tamara-Isabel Puga-Iglesias, Katarzyna Kuleszewicz, Maximilien Vanleene, Sandra J Shefelbine, George Bou-Gharios, Nicholas M Fisk, Anna L David, Paolo De Coppi, Pascale V Guillot

Get full text